Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$656M |
| 2 |
S&P Global
SPGI
|
+$588M |
| 3 |
Tesla
TSLA
|
+$386M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$247M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$561M |
| 2 |
United Therapeutics
UTHR
|
+$499M |
| 3 |
Flutter Entertainment
FLUT
|
+$445M |
| 4 |
WRK
WestRock Company
WRK
|
+$308M |
| 5 |
Visa
V
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18% |
| 2 | Consumer Discretionary | 6.63% |
| 3 | Financials | 5.84% |
| 4 | Healthcare | 4.98% |
| 5 | Industrials | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
BioCryst Pharmaceuticals
BCRX
$2.35B
| $1.16M | ﹤0.01% |
152,923
+35,978
| +31% | +$273K |
|
|
LADR
3052
Ladder Capital
LADR
$1.23B
| $1.16M | ﹤0.01% |
100,071
+59,381
| +146% | +$704K |
|
3053
Teekay
TK
$983M
| $1.16M | ﹤0.01% |
125,953
+51,278
| +69% | +$426K |
|
3054
PACS Group
PACS
$7.44B
| $1.16M | ﹤0.01% |
28,965
+23,279
| +409% | +$846K |
|
3055
Monro
MNRO
$421M
| $1.16M | ﹤0.01% |
40,113
+12,827
| +47% | +$332K |
|
3056
Amalgamated Financial
AMAL
$1.48B
| $1.16M | ﹤0.01% |
36,852
+3,918
| +12% | +$119K |
|
3057
Alamos Gold
AGI
$11.9B
| $1.16M | ﹤0.01% |
57,914
+37,977
| +190% | +$697K |
|
3058
Life Time Group Holdings
LTH
$9.88B
| $1.16M | ﹤0.01% |
47,299
+22,512
| +91% | +$506K |
|
3059
Compass Diversified
CODI
$756M
| $1.15M | ﹤0.01% |
52,185
+34,326
| +192% | +$748K |
|
3060
Scholastic
SCHL
$789M
| $1.15M | ﹤0.01% |
36,052
+11,939
| +50% | +$381K |
|
3061
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
| $1.15M | ﹤0.01% |
18,398
| – | – |
|
3062
Franklin FTSE India ETF
FLIN
$2.76B
| $1.15M | ﹤0.01% |
27,529
+402
| +1% | +$16.4K |
|
3063
HSBC
HSBC
$367B
| $1.15M | ﹤0.01% |
25,500
-1,448,042
| -98% | -$62.8M |
|
3064
Warby Parker
WRBY
$3.19B
| $1.15M | ﹤0.01% |
70,518
+45,086
| +177% | +$679K |
|
3065
BioLife Solutions
BLFS
$1.55B
| $1.15M | ﹤0.01% |
45,980
+20,050
| +77% | +$474K |
|
3066
CALL
Snowflake
SNOW
$103B
| $1.15M | ﹤0.01% |
10,000
-15,000
| -60% | -$1.84M |
|
3067
CRISPR Therapeutics
CRSP
$4.77B
| $1.15M | ﹤0.01% |
24,422
-13,682
| -36% | -$694K |
|
3068
Fluence Energy
FLNC
$1.79B
| $1.15M | ﹤0.01% |
50,505
+31,380
| +164% | +$567K |
|
3069
Harrow
HROW
$1.45B
| $1.15M | ﹤0.01% |
25,502
+15,768
| +162% | +$533K |
|
3070
Franklin US Low Volatility High Dividend Index ETF
LVHD
$629M
| $1.15M | ﹤0.01% |
28,123
-438
| -2% | -$16.9K |
|
3071
AMC Entertainment Holdings
AMC
$2.47B
| $1.14M | ﹤0.01% |
251,448
+30,876
| +14% | +$154K |
|
3072
Blue Bird Corp
BLBD
$2.36B
| $1.14M | ﹤0.01% |
23,847
+1,765
| +8% | +$87.2K |
|
3073
CALL
Agios Pharmaceuticals
AGIO
$1.95B
| $1.14M | ﹤0.01% |
+25,700
| New | +$1.17M |
|
|
3074
PUT
Agios Pharmaceuticals
AGIO
$1.95B
| $1.14M | ﹤0.01% |
+25,700
| New | +$1.17M |
|
|
HDV
3075
iShares Core High Dividend ETF
HDV
$14.5B
| $1.14M | ﹤0.01% |
48,525
+15,550
| +47% | +$356K |
|
Similar funds
Citigroup's Q3 2024 Portfolio in Review
As of Q3 2024, Citigroup held 5,895 positions worth $173B, up 11% from $156B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup deployed $7.75B of net new capital in Q3 2024, opening 351 new positions and adding to 3,206 existing holdings. Its largest new stake was Smurfit Westrock: 1,562,261 shares worth $77.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $561M trimmed.
- Citigroup's largest Q3 2024 buy was Smurfit Westrock: 1,562,261 shares worth $77.2M.
- Citigroup added most to Caterpillar in Q3 2024, an estimated $656M increase.
- Citigroup's biggest Q3 2024 reduction was iShares Russell 2000 ETF, cutting an estimated $561M.
- Citigroup fully exited WestRock Company in Q3 2024, selling an estimated $308M.
- Citigroup's ten largest holdings make up 21% of its $173B portfolio in Q3 2024.
- Citigroup opened 351 new positions and closed 235 in Q3 2024.
- Citigroup's portfolio value rose 11% quarter-over-quarter to $173B.
Based on Citigroup's 13F filing for Q3 2024, filed 12 Nov 2024.